ARCHITECT ANTI-HBS
Report
- Report Number
- 3008344661-2025-00184
- Event Type
- Malfunction
- Date Received
- December 16, 2025
- Date of Event
- November 27, 2025
- Report Date
- February 20, 2026
- Manufacturer
- ABBOTT IRELAND DIAGNOSTICS DIVISION
- Product Code
- LOM
- UDI-DI
- 00380740138059
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- JA
- Reporter Occupation
- OTHER HEALTH CARE PROFESSIONAL
- Health Professional
- Yes
Narratives
THE COMPLAINT INVESTIGATION INCLUDED A REVIEW OF DATA AND INFORMATION PROVIDED BY THE CUSTOMER, SEARCH FOR SIMILAR COMPLAINTS, TRENDING REVIEW, LABELING REVIEW, DEVICE HISTORY RECORD REVIEW AND IN HOUSE TESTING OF ARCHITECT ANTI-HBS REAGENT, LOT 75318FZ00. DATA AND INFORMATION PROVIDED BY THE CUSTOMER WERE REVIEWED AND SUPPORT THE COMPLAINT ISSUE WITHOUT INDICATION FOR ANY ADDITIONAL ISSUE. REVIEW OF TRACKING AND TRENDING FOR THE ARCHITECT ANTI-HBS ASSAY DID NOT IDENTIFY AN INCREASE IN COMPLAINT ACTIVITY RELATED TO THE COMPLAINT ISSUE. ADDITIONALLY, AN INCREASE IN COMPLAINT ACTIVITY WAS NOT IDENTIFIED FOR ANTI-HBS REAGENT LOT 75318FZ00. IN-HOUSE SPECIFICITY TESTING OF A RETAINED KIT OF LOT 75318FZ00 WAS COMPLETED. ALL SPECIFICATIONS WERE MET, INDICATING THE LOT IS PERFORMING AS EXPECTED. DEVICE HISTORY RECORD REVIEW DID NOT IDENTIFY ANY NON-CONFORMANCES OR DEVIATIONS ASSOCIATED WITH THE COMPLAINT LOT AND THE COMPLAINT ISSUE. THE PRODUCT LABELLING PROVIDES APPROPRIATE INFORMATION RELATED TO THE CUSTOMER ISSUE. BASED ON OUR INVESTIGATION, NO SYSTEMIC ISSUE OR DEFICIENCY WITH THE ARCHITECT ANTI-HBS REAGENT LOT 75318FZ00 WAS IDENTIFIED.
THIS REPORT IS BEING FILED ON AN INTERNATIONAL PRODUCT, LIST NUMBER 7C18 THAT HAS A SIMILAR PRODUCT DISTRIBUTED IN THE US, LIST NUMBER 1L82, WITH 510K/PMA/BLA NUMBER P050051. AN EVALUATION IS IN PROCESS. A FOLLOW-UP REPORT WILL BE SUBMITTED WHEN THE EVALUATION IS COMPLETE.
THE CUSTOMER OBSERVED FALSE REACTIVE ARCHITECT ANTI-HBS FOR MULTIPLE PATIENTS THAT WERE NOT REPORTED OUT OF THE LABORATORY. BEGINNING IN (B)(6), THE CUSTOMER NOTED THAT PATIENT INITIAL RESULTS WERE POSITIVE, BUT WHEN REPEATED WOULD BE NEGATIVE. THERE WAS NO SPECIFIC PATIENT RESULTS PROVIDED. THERE WAS NO IMPACT TO PATIENT MANAGEMENT REPORTED.
THE CUSTOMER OBSERVED FALSE REACTIVE ARCHITECT ANTI-HBS FOR MULTIPLE PATIENTS THAT WERE NOT REPORTED OUT OF THE LABORATORY. BEGINNING IN AUGUST, THE CUSTOMER NOTED THAT PATIENT INITIAL RESULTS WERE POSITIVE, BUT WHEN REPEATED WOULD BE NEGATIVE. THERE WAS NO SPECIFIC PATIENT RESULTS PROVIDED. THERE WAS NO IMPACT TO PATIENT MANAGEMENT REPORTED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1876321 | ARCHITECT ANTI-HBS | TEST, HEPATITIS B (B CORE, BE ANTIGEN, BE ANTIBODY, B CORE IGM) | LOM | ABBOTT IRELAND DIAGNOSTICS DIVISION | 75318FZ00 | 00380740138059 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | NA | Unknown | ARC I2K PROC MOD, 03M74-01, (B)(6). |